Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | SWI:SNF matrix associated | 0.000433847 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.000433847 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.000433847 | 1 | 1 |
Leishmania major | cytochrome p450-like protein | 0.000406623 | 0.903603 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.000266707 | 0.408177 | 0.408177 |
Chlamydia trachomatis | DNA topoisomerase I | 0.000433847 | 1 | 0.5 |
Loa Loa (eye worm) | CYP4Cod1 | 0.000406623 | 0.903603 | 0.903603 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.000406623 | 0.903603 | 0.903603 |
Brugia malayi | Cytochrome P450 family protein | 0.000406623 | 0.903603 | 0.903603 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.000433847 | 1 | 1 |
Trypanosoma brucei | cytochrome P450, putative | 0.000406623 | 0.903603 | 1 |
Chlamydia trachomatis | SWIB complex protein | 0.000433847 | 1 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.000406623 | 0.903603 | 1 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.000433847 | 1 | 1 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.000433847 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.000406623 | 0.903603 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.000433847 | 1 | 1 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.000433847 | 1 | 1 |
Loa Loa (eye worm) | brahma associated protein | 0.000433847 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.000406623 | 0.903603 | 0.903603 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.000433847 | 1 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.000433847 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.000433847 | 1 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.000433847 | 1 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.000433847 | 1 | 1 |
Onchocerca volvulus | 0.000433847 | 1 | 1 | |
Brugia malayi | brahma associated protein 60 kDa | 0.000433847 | 1 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.000433847 | 1 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.000406623 | 0.903603 | 0.903603 |
Trypanosoma cruzi | cytochrome P450, putative | 0.000406623 | 0.903603 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.000433847 | 1 | 1 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.000433847 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.000433847 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.000433847 | 1 | 1 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.000433847 | 1 | 1 |
Schistosoma mansoni | brg-1 associated factor | 0.000433847 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 1.3 uM | Antiplasmodial activity against Plasmodium falciparum K1 by [3H]hypoxanthine incorporation assay | ChEMBL. | 18247550 |
IC50 (functional) | = 1.3 uM | Antiplasmodial activity against Plasmodium falciparum K1 by [3H]hypoxanthine incorporation assay | ChEMBL. | 18247550 |
IC50 (functional) | = 5.9 uM | Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB900 | ChEMBL. | 18247550 |
IC50 (functional) | = 5.9 uM | Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB900 | ChEMBL. | 18247550 |
IC50 (ADMET) | = 239.7 uM | Cytotoxicity against rat L6 cells | ChEMBL. | 18247550 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Trypanosoma brucei gambiense | 18247550 | ||
Plasmodium falciparum | ChEMBL23 | 18247550 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.